Press Releases

Press Releases

IVI to Accelerate Efforts in iNTS Vaccine Development

IVI acquires GCLP certification from Korean Ministry of Food and Drug Safety

IVI Awarded $4.5 Million Grant to Increase Accessibility of Oral Cholera Vaccine

IVI Discusses Expanding Support for Global Collaboration on Vaccine R&D and Delivery with Top Foreign Diplomats in Seoul

IVI-led Consortium Awarded Fleming Fund Regional Grant to Improve Data Sharing in Fight against Antimicrobial Resistance

IVI to help developing countries tackle the spread of infectious diseases by building capacity through vaccinology training in Seoul

IVI acquires supplemental funding for Severe Typhoid in Africa Program (SETA Plus)

IVI Director General Dr. Jerome Kim to join the Human Vaccines Project’s Efforts as One of Four Distinguished Global Leaders to Decode the Human Immune System

Prof. Young Chul Sung, biotech leader, personally donates US$8.4 million to IVI

New push to develop world’s first vaccine against the deadly Strep A bacteria killing hundreds of thousand

IVI-led CAPTURA consortium wins Fleming Fund award for work on antimicrobial resistance (AMR) data across Asia

IVI receives $15.7 million grant to conduct phase III trials of new Vi-DT typhoid conjugate vaccine manufactured by SK bioscience of Korea

‘IVI Forum for Enhancement of Cooperation’ hosted jointly by the Korean Parliamentary Forum for Global Health, and KCDC under MOHW

Vaccine study confirms sensitivity of cholera test

Korean Pediatric Association, IVI, KSC exchange MOU

IVI receives $3.2 million grant to support TCV effectiveness studies in West Africa

CEPI partners with IVI to accelerate development of vaccines against emerging global health threats

Henry Lau joins IVI as Goodwill Ambassador

Nature Communications study addresses MDR typhoid

THSTI, IVI held joint symposium on Nov. 22

‘The Euvichol story’ published in Vaccine

IVI accelerates development of MERS vaccine

IVI’s 18th Vaccinology Course gathers 120 international participants from 19 countries in Seoul September 3-7

KOICA, IVI team up with Mozambican MoH and INS, partners to vaccinate 190,000 people against cholera

IVI acquires $5 million grant to support process development, scale up of typhoid conjugate vaccine with SK Bioscience

×

BID INVITATION

Author
ivi
Date
2018-04-10 05:32
Views
921

BID INVITATION


The International Vaccine Institute (IVI) now invites sealed proposals from interested suppliers for the supply of following goods.

1. Ref. No: IVI-LSD/2018-0410
2. Time limit to submit the proposals: 17:00 hr on April 20, 2018
3. Goods to supply: Optimal Preparative Liquid Chromatography System x 1Set
4. Technical specification: See attachment 2: Commodity Description.
5. Documents to submit: See attachment 1: Bid Guideline.

IVI reserves the right to cancel the bidding procedure if bids are not qualified and negotiate the contract details with short-listed bidders. The successful bidder shall be notified to accept and sign the contract at the earliest.

Interested parties, please submit the requested information to:

Ms. Seonwoo Yoon / Purchasing Specialist
International Vaccine Institute
SNU Research Park, 1 Gwanak-ro, Gwanak-gu,
Seoul, Korea 08826

For more details, please contact Ms. Seonwoo Yoon at 02-881-1240 or swyoon@ivi.int.
Attachment : Bid_Guideline.docx
DONATE